Browse Drug Recalls
17,874 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 17,874 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 17,874 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jan 24, 2022 | REMfresh Advanced Ion-Powered Melatonin (Melatonin 2 mg) Caplets, packaged in... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Cold Relief (acetaminophen 250 mg, guaifenesin 200mg, phenylephrine HCl 5 mg)... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Dologen (acetaminophen 325 mg and dexbrompheniramine maleate 1mg) caplets, pa... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Ephedrine Plus (Ephedrine HCl 25mg, Guaifenesin 200mg) tablets, 24-count bott... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 24, 2022 | Maximum Strength Non Aspirin Pain Reliever/Fever Reducer (acetaminophen 500 m... | cGMP deviations | Class II | Ultra Seal Corporation |
| Jan 21, 2022 | Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) top... | cGMP deficiencies | Class II | Mylan Pharmaceuticals Inc |
| Jan 19, 2022 | Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Labo... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 19, 2022 | Azacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's ... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 19, 2022 | Azacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's... | Failed stability specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 18, 2022 | Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 ... | Failed Dissolution Specification: Dissolution results are below specification limits for the acti... | Class II | Teva Pharmaceuticals USA |
| Jan 14, 2022 | Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only... | Failed Impurities/Degradation Specifications | Class II | Aurobindo Pharma USA Inc. |
| Jan 14, 2022 | Lexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY,... | CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam. | Class II | Mayne Pharma Inc |
| Jan 12, 2022 | Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Rx Only, 100 Table... | Failed Dissolution Specifications. | Class II | Ascend Laboratories, LLC |
| Jan 11, 2022 | Lung Cleaner (saline eucalyptus) inhaler, 37 oz cans, Manufactured For: The L... | cGMP deviations | Class II | Pharmasol Corporation |
| Jan 11, 2022 | 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), 50 mL vials, ... | Lack of Assurance of Sterility | Class II | Exela Pharma Sciences LLC |
| Jan 10, 2022 | Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50)... | CGMP Deviations | Class II | Ingenus Pharmaceuticals Llc |
| Jan 10, 2022 | Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals US... | Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution. | Class II | Teva Pharmaceuticals USA |
| Jan 10, 2022 | Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, pack... | Subpotent drug | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 7, 2022 | Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by... | Failed Stability Specifications | Class II | VistaPharm, Inc. |
| Jan 7, 2022 | Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packag... | Mislabeling | Class III | Teva Pharmaceuticals USA |
| Jan 7, 2022 | Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, package... | Mislabeling | Class III | Teva Pharmaceuticals USA |
| Jan 5, 2022 | Semglee (insulin glargine) injection, 100 units/mL (U-100), 3 mL Prefilled Pe... | Labeling: Missing Label: label missing from some Semglee prefilled pens. | Class I | Mylan Pharmaceuticals Inc |
| Jan 5, 2022 | Sufentanil Citrate Injection, USP 100 mcg/2 mL (50 mcg/mL) for intravenous an... | Subpotent Drug: Out of specification for assay at the 30-month stability timepoint. | Class II | Akorn, Inc. |
| Jan 4, 2022 | Rugby, Antihistamine and Nasal Decongestant, Fexofenadine HCl 60mg and Pseudo... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Wal-Fex D, Fexofenadine HCl 60mg/Antihistamine & Pseudoephedrine HCl 120mg/Na... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Dr. Reddys, Fexofenadine HCl 60 mg & Pseudoephedrine HCl 120 mg Extended-Rele... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Rite Aid Pharmacy, Allergy & Congestion, Fexofenadine HCl 60mg & Pseudoephedr... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Leader, 12HR Allergy & Congestion Relief, Fexofenadine HCl, 60mg Pseudoephedr... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | Kroger, Allergy Relief-D, Fexofenadine HCl 60mg/Antihistamine Pseudoephedrine... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | equate, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine, Pseudoephedrin... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | QC QUALITY CHOICE, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Exten... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Jan 4, 2022 | CVS Health, Allergy Relief D, Fexofenadine HCl 60mg/Antihistamine Pseudoephe... | Failed Dissolution Specifications | Class III | Dr. Reddy's Laboratories, Inc. |
| Dec 31, 2021 | MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 1... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 31, 2021 | Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose... | Lack of Assurance of Sterility | Class II | Teva Pharmaceuticals USA |
| Dec 31, 2021 | Metoprolol Tartrate Tablets, USP 25 mg, 1000 - count bottle, Rx Only, Distrib... | Complaint received of foreign matter (metal) embedded in tablet. | Class II | Rubicon Research Private Limited |
| Dec 30, 2021 | Metformin 750 mg Extended Release NDC # 70518-2920-00 | CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Da... | Class II | RemedyRepack Inc. |
| Dec 29, 2021 | Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, ... | Out-of-specification impurity test result observed at 18-month long term stability time point. | Class III | Lupin Pharmaceuticals Inc. |
| Dec 29, 2021 | Cefixime 400 mg capsule, packaged in a) 2-count bottle (NDC 70518-2749-02), b... | Failed Impurities/Degradation Specifications | Class II | RemedyRepack Inc. |
| Dec 29, 2021 | Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo... | Superpotent and Failed Tablet/Capsule Specifications | Class II | Aurobindo Pharma USA Inc. |
| Dec 27, 2021 | Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE ... | CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Da... | Class II | VIONA PHARMACEUTICALS INC |
| Dec 27, 2021 | Nitroglycerin Lingual Spray, 400 mcg per spray, 200 metered sprays, 12 g bott... | Defective Delivery System | Class II | Padagis US LLC |
| Dec 22, 2021 | Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured ... | Failed Stability Specifications: Out-of-specification results observed in a water loss test that ... | Class III | Lupin Pharmaceuticals Inc. |
| Dec 21, 2021 | Cefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem ... | Failed impurities/degradation specifications | Class II | Ascend Laboratories, LLC |
| Dec 21, 2021 | Medroxyprogesterone Acetate Injection, IM, 150 mg/mL, packaged in 1 ml Single... | Lack of Assurance of Sterility | Class II | Ideal Specialty Apothecary, Inc. dba Ideal Phar... |
| Dec 21, 2021 | SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per... | Microbial Contamination of Non-Sterile Product | Class I | Lohxa, LLC |
| Dec 20, 2021 | Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, R... | Failed Dissolution Specifications | Class II | American Health Packaging |
| Dec 16, 2021 | Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) ... | Subpotent | Class II | Teva Pharmaceuticals USA |
| Dec 15, 2021 | Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro ... | Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria | Class I | Taro Pharmaceuticals U.S.A., Inc. |
| Dec 8, 2021 | Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottl... | Defective Container: The notch in the cap that fits into the nozzle of the dropper could break of... | Class II | Teva Pharmaceuticals USA |
| Dec 7, 2021 | Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distri... | Defective Container: Leaking containers. | Class II | Direct Rx |
Frequently Asked Questions
When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.